Quantum Biopharma Ltd. Files April 2025 6-K Report

Ticker: QNTM · Form: 6-K · Filed: Apr 3, 2025 · CIK: 1771885

Quantum Biopharma Ltd. 6-K Filing Summary
FieldDetail
CompanyQuantum Biopharma Ltd. (QNTM)
Form Type6-K
Filed DateApr 3, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, regulatory-update, pharmaceutical

TL;DR

Quantum Biopharma filed its April 6-K, confirming 20-F reporting.

AI Summary

Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on April 3, 2025, reporting for the month of April 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, operates in the Pharmaceutical Preparations sector. This filing indicates they are submitting their report under Form 20-F.

Why It Matters

This filing provides an update on Quantum Biopharma's regulatory reporting status, confirming their adherence to SEC requirements for foreign private issuers.

Risk Assessment

Risk Level: low — This is a routine periodic filing and does not contain new material financial or operational information.

Key Numbers

  • 001-39152 — SEC File Number (Identifies the company's filing with the SEC.)

Key Players & Entities

  • Quantum Biopharma Ltd. (company) — Filer
  • FSD Pharma Inc. (company) — Former company name
  • April 3, 2025 (date) — Filing date
  • Toronto, Ontario (location) — Company headquarters
  • 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
  • 001-39152 (sec_file_number) — SEC file number

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K filing is to report for the month of April 2025 and to indicate that the registrant files annual reports under cover of Form 20-F.

What was Quantum Biopharma Ltd.'s former name?

Quantum Biopharma Ltd.'s former name was FSD Pharma Inc., with a date of name change on March 27, 2019.

Where is Quantum Biopharma Ltd. headquartered?

Quantum Biopharma Ltd. is headquartered at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.

What is Quantum Biopharma Ltd.'s Standard Industrial Classification code?

Quantum Biopharma Ltd.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.

Does this filing indicate submission in paper format?

The filing notes that Regulation S-T Rule 101(b)(1) only permits paper submission of a Form 6-K if submitted solely to provide an attached annual report, and the checkmark for paper submission is not indicated.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on April 3, 2025 regarding Quantum Biopharma Ltd. (QNTM).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.